# Know what treatment results can tell you *What the Evidence Means | Hip Pain Treatment Phoenix* > Hip pain treatment Phoenix facts explained plainly, including what results can show and why the sore area matters. This page tells you what treatment information can and can't prove. A clear answer starts with the right kind of hip soreness. ## Match the treatment to the sore tissue A treatment tested for joint wear doesn't answer a question about an outer-hip tendon. The joint and tendon are different tissues that react to different loads. The joint has smooth cartilage over bone, while a tendon ties muscle to bone. So the exam location matters before any treatment result applies to you. Results from knees don't settle what happens in hips, either. The hip sits deeper and carries force through a different joint shape. Animal studies can show how joint tissue reacts under set conditions, but they can't tell us how much relief a person will feel while walking, sleeping, or climbing stairs. Human care needs human results that measure those everyday changes. ## Ask what changed in daily life A lower soreness score can be real yet too small to help your walk. Useful results include sleep, stairs, getting dressed, and how long you can stand. People may improve because the body calms, activity changes, or they expect help. A fair comparison helps sort the treatment effect from those other reasons. Small studies leave more doubt because a few unusual results can sway the average. Longer follow-up also matters when you want relief that lasts. Look for risks as well as likely gains. A choice isn't useful when its harm outweighs the relief you may get. Ask how people like you did and what risks came with the care. At QC Kinetix, medical providers—the licensed clinic staff who examine your hip and provide care—can discuss regenerative treatments, or non-surgical clinic choices. ## Sources 1. The 2026 Cochrane update of exercise for hip osteoarthritis (18 trials, 1368 participants) found that against attention control or placebo, exercise may have little to no effect on pain (MD -6.31 points on 0-100, 95% CI -12.98 to 0.35, low certainty) and may improve physical function only slightly; against no treatment or usual care it probably reduces pain slightly (MD -7.19, 95% CI -10.70 to -3.68, moderate certainty) but the review states these improvements are unlikely to be clinically meaningful. This is a weaker result than the equivalent knee evidence and it must not be overstated. Hall M, et al. — [Exercise for osteoarthritis of the hip.](https://pubmed.ncbi.nlm.nih.gov/42486497/). *Cochrane Database of Systematic Reviews*, 2026. DOI: 10.1002/14651858.CD007912.pub3. 2. A Bayesian network meta-analysis of 11 randomized trials (1353 patients) in hip osteoarthritis found that at 2-4 months and 6 months NO injectable - corticosteroid, hyaluronic acid or platelet-rich plasma - significantly outperformed a saline placebo injection for pain or function. Pooled change from baseline exceeded the minimal clinically important difference in every arm including placebo. Gazendam A, et al. — [Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials.](https://pubmed.ncbi.nlm.nih.gov/32829298/). *British Journal of Sports Medicine*, 2021. DOI: 10.1136/bjsports-2020-102179. 3. The AAOS evidence-based clinical practice guideline on Management of Osteoarthritis of the Hip states verbatim: STRONG evidence supports intra-articular corticosteroids to improve function and reduce pain in the SHORT TERM; STRONG evidence does NOT support intra-articular hyaluronic acid, because it does not perform better than placebo for function, stiffness and pain; STRONG evidence supports physical therapy for mild to moderate symptoms; STRONG evidence supports NSAIDs for short-term pain and function; and MODERATE evidence does not support glucosamine sulfate. American Academy of Orthopaedic Surgeons — [Management of Osteoarthritis of the Hip: Evidence-Based Clinical Practice Guideline.](https://www.aaos.org/oahcpg). *AAOS*, 2017. 4. FDA states verbatim that regenerative medicine products including stem cells, stromal vascular fraction, umbilical cord blood, Wharton's jelly, amniotic fluid and exosomes have NOT been approved 'for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' The only FDA-approved stem cell products in the United States are blood-forming (hematopoietic progenitor) cells derived from umbilical cord blood, approved only for disorders affecting blood production. U.S. Food and Drug Administration — [Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes.](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes). *FDA*, 2026. 5. A 106-patient double-blind RCT found a single INTRAMUSCULAR gluteal injection of 40 mg triamcinolone reduced hip pain at rest more than placebo at 2 weeks (difference -1.3, 95% CI -2.3 to -0.3) with effects on walking pain and WOMAC pain persisting to 12 weeks - relevant because intramuscular injection avoids entering the joint. Dorleijn DMJ, et al. — [Intramuscular glucocorticoid injection versus placebo injection in hip osteoarthritis: a 12-week blinded randomised controlled trial.](https://pubmed.ncbi.nlm.nih.gov/29514801/). *Annals of the Rheumatic Diseases*, 2018. DOI: 10.1136/annrheumdis-2017-212628. 6. A meta-analysis of four randomized trials comparing PRP with hyaluronic acid in hip OA found PRP associated with a significant VAS reduction at 2 months but NO significant advantage at 6 or 12 months, and no difference in WOMAC or Harris Hip Score at 12 months. Ye Y, et al. — [Platelet rich plasma versus hyaluronic acid in patients with hip osteoarthritis: A meta-analysis of randomized controlled trials.](https://pubmed.ncbi.nlm.nih.gov/29626641/). *International Journal of Surgery*, 2018. DOI: 10.1016/j.ijsu.2018.03.078. 7. A systematic review of five randomized trials of intra-articular PRP for hip OA (43-111 patients each) reported significant pain reduction and functional improvement in every included study with no major adverse events, but methodological quality ranged from low to high risk of bias and PRP preparation methods differed between studies - so this positive summary rests on a small and heterogeneous base and does not override the placebo-controlled network meta-analysis. Almutairi AN, Alazzeh MS — [Efficacy and Safety of Platelet-Rich Plasma (PRP) Intra-articular Injections in Hip Osteoarthritis: A Systematic Review of Randomized Clinical Trials.](https://pubmed.ncbi.nlm.nih.gov/39569300/). *Cureus*, 2024. DOI: 10.7759/cureus.72057. 8. In a placebo-controlled, participant- and assessor-blinded RCT of 102 people with radiographically confirmed hip OA, 12 weeks of active physical therapy (education, manual therapy, home exercise, gait aid) did NOT beat sham ultrasound and inert gel on pain (mean difference 6.9 mm favouring sham, 95% CI -3.9 to 17.7) or function at week 13, and mild adverse effects were more common in the active group (41% vs 14%). Bennell KL, et al. — [Effect of physical therapy on pain and function in patients with hip osteoarthritis: a randomized clinical trial.](https://pubmed.ncbi.nlm.nih.gov/24846036/). *JAMA*, 2014. DOI: 10.1001/jama.2014.4591. ## Bring your hip questions to an exam Licensed clinic staff can examine your hip, review your health history, and explain the non-surgical choices that may fit. Book a free consultation: --- Clear answers for a hip that is slowing you down. Plain help for a sore hip, from common causes and home care to visits and non-surgical choices in Phoenix. Plain help for understanding hip soreness, home care, warning signs, and visits in Phoenix. This evidence desk is operated by the business owners of the QC Kinetix Phoenix-area clinics, who may benefit when a reader arranges a visit. Copyright 2026 Phoenix Hip Evidence Desk. Use these field notes for education, then let an examining clinician shape decisions for your own hip.